Ocular Therapeutix Waiting for Word from FDA

Ocular Therapeutix - Innovation Showcase at Ophthalmology Innovation Summit @ ASCRS 2019Подробнее

Ocular Therapeutix Taking Aim at Allergy MarketПодробнее

How to: DEXTENZA insert by OcularПодробнее

How AI is helping physicians make more informed diabetic retinopathy referralsПодробнее

Ocular TherapeuticsПодробнее

StimuleyesПодробнее

Ocular TherapeutixПодробнее

Ocular Therapeutix’s Sawhney Discusses Regeneron, FDA (OIS@AAO 2016)Подробнее

Dextenza receives FDA approval for ocular itching associated with allergic conjunctivitisПодробнее

FDA approves new device to quickly detect strokesПодробнее

Drug, Diagnostic and Device Development: From Scientific Findings to FDA ApprovalПодробнее

Focus on eyes: Delivering patient treatment on time ─ Quality Awards 2018Подробнее

FDA considers warning to patients seeking Lasik surgery | FOX 13 SeattleПодробнее

Don’t Lose Sight of Your Vision (Short Video)Подробнее

Payer Coverage Decisions vs FDA Labelling in Wet AMDПодробнее

ECP CureSight video EUR- FDAПодробнее

CureSight Patient video (FDA cleared) - Hebrew SubsПодробнее

Will FDA Approve Pegcetacoplan?Подробнее

Eye doctor explains FDA-approved alternative to LASIKПодробнее